Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Gets a Neutral rating from Barclays

11/13/2020 | 02:44am EST

Emily Field from Barclays retains his Neutral opinion on the stock. The target price has been revised upwards and is now set at EUR 130, compared with EUR 125 previously.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
BARCLAYS PLC 1.10% 150.58 Delayed Quote.1.45%
MERCK KGAA -0.20% 148.6 Delayed Quote.6.09%
All news about MERCK KGAA
01/14KONINKLIJKE PHILIPS N : Philips Teams Up With Merck to Develop Digital Products ..
MT
01/14DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -3-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -2-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
01/13MERCK KGAA : JP Morgan keeps its Buy rating
MD
01/11DGAP-PVR : Merck KGaA: Release according to -6-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -5-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -3-
DJ
More news
Financials
Sales 2020 17 359 M 20 932 M 20 932 M
Net income 2020 1 973 M 2 379 M 2 379 M
Net Debt 2020 11 104 M 13 389 M 13 389 M
P/E ratio 2020 32,6x
Yield 2020 0,94%
Capitalization 64 738 M 78 272 M 78 063 M
EV / Sales 2020 4,37x
EV / Sales 2021 4,07x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 137,28 €
Last Close Price 148,90 €
Spread / Highest target 13,5%
Spread / Average Target -7,81%
Spread / Lowest Target -32,2%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA6.09%78 272
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD6.24%26 461
KYOWA KIRIN CO., LTD.0.14%14 584
BETTA PHARMACEUTICALS CO., LTD.12.74%7 529
YUHAN CORPORATION1.60%4 306
RECIPHARM AB (PUBL)1.19%2 674